GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genomic Valley Biotech Ltd (BOM:539206) » Definitions » Scaled Net Operating Assets

Genomic Valley Biotech (BOM:539206) Scaled Net Operating Assets : 0.00 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Genomic Valley Biotech Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Genomic Valley Biotech's operating assets for the quarter that ended in Dec. 2024 was ₹0.00 Mil. Genomic Valley Biotech's operating liabilities for the quarter that ended in Dec. 2024 was ₹0.00 Mil. Genomic Valley Biotech's Total Assets for the quarter that ended in Sep. 2024 was ₹41.61 Mil. Therefore, Genomic Valley Biotech's scaled net operating assets (SNOA) for the quarter that ended in Dec. 2024 was 0.00.


Genomic Valley Biotech Scaled Net Operating Assets Historical Data

The historical data trend for Genomic Valley Biotech's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomic Valley Biotech Scaled Net Operating Assets Chart

Genomic Valley Biotech Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 0.75 0.38 0.92 0.80

Genomic Valley Biotech Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Genomic Valley Biotech's Scaled Net Operating Assets

For the Biotechnology subindustry, Genomic Valley Biotech's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomic Valley Biotech's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genomic Valley Biotech's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Genomic Valley Biotech's Scaled Net Operating Assets falls into.


;
;

Genomic Valley Biotech Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Genomic Valley Biotech's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2024 )
=(Operating Assets (A: Mar. 2024 )-Operating Liabilities (A: Mar. 2024 ))/Total Assets (A: Mar. 2023 )
=(43.276-7.916)/44.204
=0.80

where

Operating Assets(A: Mar. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=43.337 - 0.061
=43.276

Operating Liabilities(A: Mar. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=7.916 - 0 - 0
=7.916

Genomic Valley Biotech's Scaled Net Operating Assets (SNOA) for the quarter that ended in Dec. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Dec. 2024 )
=(Operating Assets (Q: Dec. 2024 )-Operating Liabilities (Q: Dec. 2024 ))/Total Assets (Q: Sep. 2024 )
=(0-0)/41.61
=0.00

where

Operating Assets(Q: Dec. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=0 - 0
=0

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomic Valley Biotech Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Genomic Valley Biotech's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomic Valley Biotech Business Description

Traded in Other Exchanges
N/A
Address
4 K.M. Stone, Berri Charra Road, P.O. Tandaheri, Tehsil-Bahadurgarh, Village Kherka Musalman, Jhajjar, HR, IND, 124507
Genomic Valley Biotech Ltd is an India-based company engaged in providing diagnostic services and related business services. It undertakes commercial production of plant tissue cultured plants of different species to feed the genetically improved plant market nationally as well as internationally. The group conducts research in the field of agriculture, plant tissue culture, medical biotechnology, SERI biotechnology, stem cell, food biotechnology, Drone technology, Poly House Construction, and others. It generates revenue from the sale of services.

Genomic Valley Biotech Headlines

No Headlines